Institutional investors hold a majority ownership of AMGN through the 82.31% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2014, these large investors purchased a net $7.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 10.2 Million shares of Amgen Inc
M&G INVESTMENT MANAGEMENT LTD. Bought 3.0 Million shares of Amgen Inc
CLEARBRIDGE INVESTMENTS LLC Bought 2.0 Million shares of Amgen Inc